EUROPEAN JOURNAL OF OPHTHALMOLOGY, cilt.27, sa.4, ss.423-427, 2017 (SCI-Expanded)
Purpose: To evaluate the therapeutic outcome of intravitreal melphalan injection in the management of vitreous disease in patients with retinoblastoma. We particularly aimed to assess whether higher melphalan dose with lower number of injections was more effective and associated with fewer side effects.